Custom-tailored hemodilution with albumin and crystalloids in acute ischemic stroke.

Abstract

This study may provide an explanation for the failures in former hemodilution trials and may re-establish proper hemodilution and rehydration as a valuable therapy in the acute phase of stroke, thus reducing mortality and improving independence after 3 months.